High expression of long noncoding RNA NORAD is associated with poor clinical outcomes in non-M3 acute myeloid leukemia patients.

Masoud Eslami, Mohammad; Soufizomorrod, Mina; Ahmadvand, Mohammad

Masoud Eslami, Mohammad; Soufizomorrod, Mina; Ahmadvand, Mohammad.

Afiliación

Masoud Eslami M; Department of Hematology, School of Medicine, Tarbiat Modares University (TMU), Tehran, Iran.
Soufizomorrod M; Department of Hematology Applied Cell Sciences, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. Electronic address: m.soufi@modares.ac.ir.
Ahmadvand M; Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Hematol Oncol Stem Cell Ther ; 2021 Aug 16.

Article en En | MEDLINE | ID: mdl-34419481

Palabras clave

Acute myeloid leukemia; Long noncoding RNA; NORAD; Prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hematol Oncol Stem Cell Ther Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Irán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google